Introduction {#S0001}
============

Adenotonsillectomy (T&A) is one of the most commonly performed surgical procedures in children in the United States (US). It is typically performed to treat symptoms of sleep-disordered breathing (SDB), obstructive sleep apnea (OSA), or recurrent tonsillitis.[@CIT0001]--[@CIT0003] Although several studies have expressed concern regarding the safety of performing T&A as an outpatient procedure in children with SDB or OSA, these procedures continue to be performed in the ambulatory setting.[@CIT0004]--[@CIT0006] The most common complications following pediatric T&A include hemorrhage and respiratory complications, which are estimated to occur in 3% and 9% of cases, respectively.[@CIT0007] In 2011, the American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNS) published a practice guideline recommending that children with complicated medical histories should undergo inpatient rather than outpatient T&A.[@CIT0003] Subsequent research has affirmed the need for overnight monitoring of patients deemed to be at high risk of complications, to prevent morbidity and even mortality after T&A in children with OSA or SDB.[@CIT0008]

The adoption of AAO-HNS practice guidelines has been inconsistent across physicians and hospitals, and admission practices after T&A continue to vary widely across institutions.[@CIT0009],[@CIT0010] Meanwhile, revisit rates after pediatric tonsillectomy also show marked variation across institutions, ranging from 3% to 13%.[@CIT0009] Recently, our group has shown that early (7-day) revisits after T&A were reduced in children who received extended postoperative monitoring.[@CIT0011] However, it remains unclear whether institutional practices favoring overnight stay after T&A impact the number of hospital revisits for any reason. Our current study examines whether greater use of overnight stay after T&A is associated with a lower risk of all-cause revisits and readmissions after T&A. We hypothesized that the likelihood of revisits would be lower in hospitals performing a higher proportion of T&A with an overnight stay (as opposed to ambulatory procedures). A secondary aim was to evaluate the rate of overnight admission across all hospitals during the study time period based on the current practice recommendations from the AAO-HNS and the recent anecdotal reports of mortality following T&A.[@CIT0003],[@CIT0008]

Methods {#S0002}
=======

This retrospective study was approved by the Institutional Review Board (IRB) of Nationwide Children's Hospital (IRB15-00264). The IRB at NCH is a hospital-based, non-University affiliated IRB that reviews and oversees all clinical research performed by members of the faculty. As a retrospective study, the need for informed consent was deemed unnecessary. The Data Resource Center at our institution extracted data from the Pediatric Health Information System (PHIS) on T&A performed among children ≤18 years of age between 2007 and 2015. The PHIS is an anonymized database containing administrative and billing data from over 40 freestanding children's hospitals affiliated with the Children's Hospital Association.[@CIT0009] All discharges from member hospitals are included in the database, and data collected include demographic information, diagnosis and procedure codes, service locations, and charges mapped to clinical transaction codes.[@CIT0009] Patients were included in this analysis if they underwent T&A on the day of admission to a participating hospital, and if they were discharged on the same day (outpatient) or 1 or more days after the procedure (overnight stay). Patients were excluded from multivariable analysis if they were missing data on study covariates. The primary outcome was all-cause inpatient readmission or revisit to an emergency department (ED) within 7 days of discharge. Inpatient readmissions or acute care revisits within 7 days are considered a key measure of complications occurring early after hospital discharge. Secondary outcomes included specific revisit types (ED visit vs readmission) and 30-day revisit outcomes.[@CIT0012],[@CIT0013] Additionally, we tracked the percentage of inpatient admission following T&A over the study period.

In the descriptive analysis, we characterized types and reasons for revisits at each time point using counts with percentages. The primary exposure was each institution's annual rate of overnight stay after T&A, categorized according to quartiles of institutions (≤20%, 21--35%, 36--60%, or \>60% of T&A performed with overnight stay). Individual-level covariates included age, gender, race, severity levels classified by the All Patient-Refined Diagnosis Related Groups system, and comorbidities, including presence of OSA or SDB symptoms, asthma, diabetes, and obesity, noted at the time of surgery, as identified from International Classification of Diseases 9th revision (ICD-9) or 10th revision (ICD-10) codes.

For descriptive analysis, hospitals' revisit rates and other study data were compared according to institutional admission practice over the entire study period (percent of T&A with overnight stay). Categorical data were analyzed using Chi-square tests, and continuous data were analyzed using ANOVA. To evaluate the association between institutional practice and individual patient's revisit risk while accounting for the clustering of patients within hospitals, we used mixed effects logistic regression adjusted for the institutional use of overnight stay, annual volume of T&A procedures (a proxy for hospital size), individual admission status after T&A (overnight stay vs outpatient), and covariates listed above. To disambiguate among outcomes of ED revisit and readmission, we created a secondary outcome with mutually exclusive categories of 1) no ED visit or readmission, 2) at least one ED visit, but no readmission, and 3) any readmission, with or without ED visits. This secondary outcome was analyzed using a mixed-effects multinomial logistic regression model, which generated pairwise comparisons among each of the three outcome categories.[@CIT0014] Analyses were repeated for 30-day outcomes. To examine whether our multivariable models were influenced by including both institutional rates of overnight stay and individual admission status, analyses were also repeated while omitting individual admission status. Data were analyzed using Stata/IC 14.2 (College Station, TX: StataCorp, LP), and two-tailed *p*\<0.05 was considered statistically significant.

Results {#S0003}
=======

There were 411,876 patients from 48 hospitals meeting inclusion criteria, of whom 344,525 had complete data for multivariable analysis. Hospitals' annual T&A volume (among cases meeting inclusion criteria) ranged from 7 to 3,143 (1,002±758). Annual rates of overnight stay after T&A ranged from 3% to 100% (44% ±31%). Annual revisit rates at 7 days after discharge ranged from 0% to 15% (5% ±3%), and revisit rates at 30 days after discharge ranged from 0% to 7% (mean: 7% ±4%). Overall, 26,908 (7%) patients had a 7-day revisit, of which 18,656 (69%) were ED visits and 8,252 (31%) were readmissions. Of these readmissions, 862 (10%) were initially seen in the ED. Among the 36,234 (9%) patients who had a 30-day revisit, 25,003 (69%) were ED visits and 11,231 (31%) were readmissions. Of these readmissions, 1,582 (14%) were initially seen in the ED. [Figure 1](#F0001){ref-type="fig"} illustrates the institutions' use of overnight stay and revisit rates after T&A over the entire study period. There was no trend of decreasing revisit rates at 7 or 30 days after discharge, regardless of the institutions' practice of using overnight stay, but there were three outlier institutions reporting \>98% rates of overnight stay after T&A and no readmissions or revisits within 30 days. In [Figure 2](#F0002){ref-type="fig"}, overall rates of ED visits are compared to overall rates of readmission across the 48 institutions; there was no evident correlation between the revisit types, with some institutions having higher rates of readmission than of ED visits after T&A. As shown in [Figure 3](#F0003){ref-type="fig"}, there has been a downward trend of performing T&A as an outpatient procedure over the study years, although it is apparent that patients with OSA/SDB symptoms still undergo T&A in the outpatient setting.Figure 1Institutional use of overnight stay after pediatric adenotonsillectomy (T&A) and revisit rates over the 2007--2015 study period, with fitted lines obtained by locally weighted regression smoothing (*N*=48 hospitals).Figure 2Rates of emergency department (ED) visits and readmissions after pediatric adenotonsillectomy (T&A) over the 2007--2015 study period, with fitted lines obtained by locally weighted regression smoothing (*N*=48 hospitals).Figure 3Outpatient procedures as a proportion of pediatric adenotonsillectomies performed over 2007--2015, by the presence of obstructive sleep apnea (OSA) or sleep-disordered breathing (SDB).

The primary reasons for 36,234 unique revisits are compared according to revisit timing and type in [Table 1](#T0004){ref-type="table"}. The most common specific reasons for 7-day revisits were dehydration (22%), bleeding (19%), and pain (15%). Readmissions within 7 days of discharge were primarily due to bleeding (42%) and dehydration (28%). Reasons for 7-day revisits were broadly similar across the categories of hospital overnight stay rates ([Table S1](#T0004){ref-type="table"}). Study outcomes and patient characteristics are compared according to institutional use of overnight stay after T&A in [Table 2](#T0005){ref-type="table"}. There were few substantive differences in patient characteristics across hospital categories, apart from relatively younger age among patients at hospitals favoring an overnight stay. Among patients undergoing T&A in each category of hospitals, 7-day revisit rates were generally similar, ranging from 6% to 7%.Table 1Reasons for revisit after adenotonsillectomy by revisit type and timing (N=411,876 patients)Revisit timing and type N (%)Within 7 daysWithin 30 daysRevisit reasonTotal cohort\
(N=411,876)All revisits\
(N=26,908)ED visit\
(N=18,656)Readmission\
(N=8,252)Total cohort\
(N=411,876)All revisits\
(N=36,234)ED visit\
(N=25,003)Readmission\
(N=11,231)Bleeding5,257 (1%)5,257 (20%)1,784 (10%)3,473 (42%)7,824 (2%)7,824 (22%)2,369 (9%)5,455 (48%)Dehydration5,836 (1%)5,836 (22%)3,492 (19%)2,344 (28%)6,122 (1%)6,122 (17%)3,635 (15%)2,487 (22%)Fever1,592 (0.4%)1,592 (6%)1,479 (8%)113 (1%)1,921 (0.5%)1,921 (5%)1,787 (7%)134 (1%)Nausea/Vomiting1,410 (0.3%)1,410 (5%)1,265 (7%)145 (2%)1,592 (0.4%)1,592 (4%)1,436 (6%)156 (1%)Pain4,015 (1%)4,015 (15%)3,632 (19%)383 (5%)4,562 (1%)4,562 (13%)4,132 (17%)430 (4%)Other8,798 (2%)8,798 (33%)7,004 (38%)1,794 (22%)14,213 (3%)14,213 (39%)11,644 (47%)2,569 (23%)[^1] Table 2Patient characteristics and outcomes according to overnight stay after adenotonsillectomy (N=411,876 patients)Patient outcomes and characteristicsMissing data (N)Institutional practice of overnight stay after T&A^a^≤20% overnight stay\
(N=100,233)\
N (%) or\
mean (SD)21--35% overnight stay\
(N=156,129)\
N (%) or\
mean (SD)36--60% overnight stay\
(N=98,482)\
N (%) or\
mean (SD)\>60% overnight stay\
(N=57,032)\
N (%) or\
mean (SD)7-day revisits0 All6,077 (6%)10,277 (7%)7,157 (7%)3,400 (6%) ED visit4,342 (4%)7,730 (5%)4,981 (5%)2,464 (4%) Readmission1,894 (2%)3,016 (2%)2,349 (2%)1,000 (2%)*3*0-day revisits0 All8,246 (8%)13,911 (9%)9,297 (9%)4,780 (8%) ED visit5,936 (6%)10,517 (7%)6,605 (7%)3,527 (6%) Readmission2,647 (3%)4,182 (3%)3,014 (3%)1,388 (2%)Patient overnight stay after T&A011,554 (12%)43,112 (28%)43,724 (44%)39,173 (69%)Age06.0 (3.6)5.9 (3.5)5.9 (3.6)5.5 (3.5)Race67,325 White46,152 (46%)94,434 (65%)63,906 (65%)26,644 (47%) African American12,770 (13%)23,576 (14%)13,678 (14%)9,092 (16%) Other16,220 (16%)14,768 (13%)13,216 (13%)10,095 (18%)Gender16 Female48,205 (48%)75,447 (48%)46,629 (47%)26,549 (47%)APR DRG Severity Level11 Minor89,497 (90%)139,097 (90%)84,179 (85%)46,931 (82%) Moderate9,645 (10%)14,630 (9%)12,232 (12%)8,514 (15%) Major967 (1%)2,125 (1%)1,866 (2%)1,387 (2%) Extreme122 (\<1%)273 (\<1%)202 (\<1%)198 (\<1%)Presence of OSA or SDB symptoms050,960 (51%)58,626 (38%)52,154 (53%)33,180 (58%)Asthma011,070 (11%)17,304 (11%)12,827 (13%)7,175 (13%)Diabetes0220 (0.2%)366 (0.2%)374 (0.4%)171 (0.3%)Obesity02,696 (3%)3,958 (3%)3,367 (3%)2,511 (4%)Year of service02011 (2.5)2011 (2.5)2011 (2.5)2011 (2.5)[^2]

Results from the multivariable analysis of the primary study outcome are shown in [Table 3](#T0006){ref-type="table"} for cases with complete data on study variables. Individual overnight admission after T&A was associated with lower odds of all-cause 7-day revisits (OR =0.74; 95% CI: 0.72, 0.77; *p*\<0.001). Among other covariates, asthma, diabetes, moderate APR DRG severity level, older age, and African American race were associated with a higher risk of 7-day revisits. However, hospital practice favoring greater use of overnight stay was not independently associated with lower 7-day revisit odds, compared to hospitals admitting ≤20% of the children undergoing T&A. The lack of association between greater institutional rates of overnight stay and lower revisit risk was confirmed after excluding individual admission status from the model ([Table S2](#T0005){ref-type="table"}), or when applying the model shown in [Table 2](#T0005){ref-type="table"} to 30-day all-cause revisits ([Table S3](#T0006){ref-type="table"}). However, hospitals with overnight stay rates of 21--35% (OR =0.93; 95% CI: 0.88, 0.98; *p*=0.012) or \>60% (OR =0.85; 95% CI: 0.78, 0.94; *p*=0.001) were associated with lower odds of 30-day revisits compared to hospitals with the highest rate of ambulatory procedures, when individual admission status was omitted from the model ([Table S3](#T0006){ref-type="table"}).Table 3Multivariable mixed-effects logistic regression analysis of 7-day revisits among patients following T&A (N=344,525)CharacteristicOR95% CI*P*Patient overnight stay after T&A0.74(0.72, 0.77)\<0.001Age1.01(1.005, 1.01)\<0.001RaceWhite1 (ref.) African American1.30(1.25, 1.35)\<0.001 Other1.07(1.02, 1.11)0.003Gender Female0.98(0.95, 1.01)0.126APR DRG Severity Level Minor1 (ref.) Moderate1.17(1.12, 1.22)\<0.001 Major1.02(0.91, 1.15)0.677 Extreme0.70(0.48, 1.01)0.060Presence of OSA or SDB symptoms1.01(0.98, 1.04)0.450Asthma1.33(1.28, 1.38)\<0.001Diabetes1.50(1.21, 1.86)\<0.001Obesity1.00(0.92, 1.08)0.965Year of service1.05(1.04, 1.06)\<0.001Annual volume of T&A procedures^a^1.02(1.01, 1.03)\<0.001Institutional practice of overnight stay after T&A ≤20% overnight stay1 (ref.) 21--35% overnight stay0.99(0.93, 1.05)0.717 36--60% overnight stay1.13(1.05, 1.22)0.002 \>60% overnight stay1.03(0.92, 1.15)0.601[^3]

To further explore the association between institutional practice and revisit type, we fitted a multinomial logistic regression model as shown in [Table 4](#T0007){ref-type="table"}. When predicting the likelihood of ED visit (without readmission) as opposed to no revisits, individual admission status was associated with lower likelihood of ED visit (OR =0.96; 95% CI: 0.92, 0.996; *p*=0.033), but there was no trend of lower ED visit likelihood at institutions with greater use of overnight stay after T&A. When predicting the likelihood of readmission as opposed to no revisits, individual overnight stay was associated with lower need for readmission (OR=0.36; 95% CI: 0.33, 0.38; *p*\<0.001), but greater institutional use of overnight stay was associated with higher likelihood of readmission. Notably, when comparing revisit types among patients requiring ED visit or readmission within 7 days of discharge, readmissions were more likely than ED visits when institutions had \>60% overnight stay after T&A as compared to ≤20% (OR =1.48; 95% CI: 1.18, 1.84; *p*=0.001).Table 4Multivariable mixed-effects multinomial logistic regression analysis of revisit type within 7 days of dischargeCharacteristicsED visit vs no revisitReadmission vs no revisitReadmission vs ED visitORCI*P*ORCI*P*ORCI*P*Overnight stay after T&A0.96(0.92, 0.996)0.0330.36(0.33, 0.38)\<0.0010.37(0.34, 0.40)\<0.001Age Race White1 (ref.) African American1.38(1.33, 1.45)\<0.0011.13(1.05, 1.21)\<0.0010.81(0.75, 0.88)\<0.001 Other1.17(1.11, 1.23)\<0.0010.86(0.79, 0.93)\<0.0010.73(0.67, 0.80)\<0.001Gender Female0.98(0.95, 1.02)0.3260.97(0.92, 1.02)0.1950.98(0.93, 1.04)0.595APR DRG Severity Level Minor1 (ref.) Moderate1.11(1.05, 1.17)\<0.0011.35(1.25, 1.45)\<0.0011.21(1.11, 1.33)\<0.001 Major0.87(0.76, 1.00)0.0511.63(1.34, 1.98)\<0.0011.87(1.47, 2.36)\<0.001 Extreme0.67(0.44, 1.01)0.0570.83(0.37, 1.86)0.6461.24(0.50, 3.07)0.636Presence of OSA or SDB symptoms1.02(0.98, 1.06)0.3141.01(0.96, 1.07)0.7410.99(0.93, 1.06)0.835Asthma1.35(1.29, 1.41)\<0.0011.29(1.20, 1.39)\<0.0010.96(0.88, 1.04)0.289Diabetes1.58(1.24, 2.02)\<0.0011.35(0.88, 2.05)0.1660.85(0.53, 1.37)0.509Obesity1.03(0.94, 1.13)0.4840.92(0.80, 1.07)0.3060.89(0.75, 1.06)0.204Year of service1.05(1.04, 1.06)\<0.0011.04(1.03, 1.05)\<0.0010.99(0.97, 1.00)0.102Annual volume of T&A procedures1.02(1.02, 1.03)\<0.0011.01(1.00, 1.02)0.1220.98(0.97, 0.99)0.004Institutional practice of overnight stay after T&A ≤20% overnight stay1 (ref.) 21--35% overnight stay0.95(0.88, 1.02)0.1291.08(0.97, 1.21)0.1721.16(1.02, 1.32)0.025 36--60% overnight stay1.11(1.02, 1.22)0.0191.18(1.03, 1.35)0.0171.07(0.91, 1.26)0.385 \>60% overnight stay0.92(0.81, 1.04)0.1941.35(1.12, 1.62)0.0021.48(1.18, 1.84)0.001[^4]

Discussion {#S0004}
==========

In 2011, the American Academy of Otolaryngology and Head and Neck Surgery published guidelines for high-quality tonsillectomy care, which recommend overnight admission after tonsillectomy for patients with a co-morbid disease such as prematurity, failure to thrive, recent respiratory infection, obesity, OSA, SDB, and neuromuscular disorders.[@CIT0003] Even with such guidelines, admission rates after tonsillectomy vary substantially across institutions. Practice variation is recognized as a critical issue in health care quality and has been identified as a serious issue in both the field of pediatric care and in the area of tonsillectomy.[@CIT0002],[@CIT0015],[@CIT0016] Despite the significant practice variation with regard to overnight stay after T&A, our study demonstrates a lack of association between hospital-level use of overnight stay, and patients' risk of acute care revisits. Therefore, there may be limited potential for reducing acute care revisits after tonsillectomy by increasing the proportion of patients who are admitted for overnight stay. However, given the rare but lethal risk of post-discharge death associated with failure to admit and monitor patients with SDB/OSA following T&A, an evaluation of admission practices is needed to ensure the safety of this common surgical procedure. Such issues continue to represent a major health care concern as, although their incidence is extremely low, the impact is obviously high. While many of these cases can be the result of the injudicious or inappropriate use of opioids in this at-risk population, continued risk stratification is needed to identify these patients and help maintain the balance between safety and effective use of health care resources. Such data may help clarify the optimal strategy for overnight admission or extended monitoring of high-risk patients undergoing T&A. Furthermore, investigations into the effective use of non-opioid adjunctive medications, including acetaminophen and non-steroidal anti-inflammatory drugs to limit perioperative opioid needs, are needed.

Previous studies have suggested revisit rates of 3.0--12.6% within 30 days after T&A in children.[@CIT0013] Planned overnight admission following T&A in children has been suggested for patients under 3 years of age, those with comorbid conditions, and those with severe OSA documented on PSG (apnea-hypopnea index of 10 or more obstructive events/hour, oxygen saturation nadir less than 80%, or both).[@CIT0003],[@CIT0017] However, the association of admission status after T&A with the risk of unplanned revisits remains contradictory. Inpatient T&A patients may have a higher risk for revisits, but this was likely confounded by greater comorbidity burden or medical complexity among patients selected for inpatient admission.[@CIT0018] We have recently demonstrated in an analysis of children enrolled in a Medicaid Accountable Care Organization that overnight admission may, in fact, be associated with a reduced risk of revisits in the short term (7 days).[@CIT0011]

The present study adds an institution-level perspective on this controversy. Contrary to our expectations, institutional variability in admission rates after T&A was not associated with institutional rates of revisits. However, this finding may be less surprising when considering that among institutions participating in the PHIS, variability in admission practice was much greater than variability in revisit outcomes after T&A Therefore, differences in hospital revisit rates after T&A may be explained by other institutional characteristics, apart from the use of overnight stay (eg, rural vs urban hospital location, availability of other institutions where patients may seek care after discharge) and differences in the case mix (eg, patients at higher risk for all-cause revisits due to greater morbidity burden).

Our secondary analysis examined specific types of revisits, distinguishing between only an ED visit versus the need for inpatient readmission. Surprisingly, institutional rates of ED visits and institutional rates of readmissions after T&A were not correlated with one another. This result suggests another reason for the possible discrepancies among the findings of prior studies, as some have defined revisits after T&A as readmissions only, while others have included both readmissions and ED visits, or readmissions, ED visits, and urgent care visits.[@CIT0001],[@CIT0009] Our study suggests that a low rate of the need for inpatient readmission alone does not necessarily suggest an overall low rate of revisits after T&A at a given institution, requiring a broad definition of revisits to draw accurate conclusions regarding post-discharge outcomes of T&A. Differences in institutional use of overnight stay for patients returning after T&A may also explain discrepancies in the past summaries of leading readmission causes. For example, some studies have reported leading causes of acute care revisits after T&A to be pain, nausea, and vomiting.[@CIT0018] However, our data showed the major reasons for revisits to be dehydration, bleeding, and fever, as described in other prior work.[@CIT0011]

At our institution, new guidelines for risk stratification of patients scheduled for T&A were implemented in 2011, determining which procedures were performed in the main operating room (OR) with inpatient admission as opposed to a free-standing ambulatory care facility.[@CIT0019] The guidelines scheduled high-risk patients who required T&A to be performed in the main OR with overnight admission. Our criteria for inpatient admission with ongoing monitoring included patients \<3 years of age; sleep study findings with an apnea-hypopnea index \>10, pulse oximetry reading \<80% or end-tidal CO~2~\>50 mmHg; clinical history of severe OSA/SDB; obesity (BMI\>95% percentile for age); craniofacial syndromes or abnormalities; and the presence of co-morbid conditions (eg, asthma, diabetes mellitus).[@CIT0018]--[@CIT0021] Implementation of these guidelines reduced unanticipated admissions, while only slightly increasing planned admissions.[@CIT0019] Our success with improving risk stratification for T&A suggests that changing the group of patients who are admitted may have a greater effect on postoperative outcomes than simply increasing the proportion of patients who are admitted.

The use of the PHIS database results in some study limitations. As this database only contains information from a select number of affiliated pediatric hospitals, it may not contain a nationally representative population of children undergoing T&As. In addition, although this database contains most inpatient readmission or ED revisits, a small number of children may have been readmitted to a hospital or ED that is not included in this database. These readmissions and revisits would be unidentified in our analysis. Finally, as with any administrative database, the PHIS database is limited by the accuracy of its data entry. In particular, since we identified patients with OSA or SDB, asthma, and diabetes and who were obese according to ICD-9 or ICD-10 codes noted at the time of surgery, correct classification of patients is determined by the accurate entry of these codes.

Our study is the first to examine whether the institutional practice of overnight stay was related to all-cause revisits after T&A. The absence of this association, particularly for 7-day outcomes that are most likely to be influenced by admission type, suggests that implications of institutional differences in the use of overnight admission may have been overstated. Nevertheless, other institutional differences in practice may be driving the institution-level variability seen in revisit rates after pediatric T&A. Although a recent study of post-discharge outcomes in older adults suggested that analyzing readmissions alone led to similar conclusions as analyzing all acute care received after discharge, our study shows that conclusions about revisits after pediatric tonsillectomy were highly sensitive to the inclusion of revisits other than readmissions in the outcome measure.[@CIT0022]

In the meantime, our present investigation of revisits in a multi-institutional registry does not support the conclusion that increasing the rate of inpatient T&A with an overnight stay will impact the revisit rate, either early (7 days) or late (30 days). Rather, current judicious use of overnight stay appears to perform well at limiting the risk of early revisits, notwithstanding practice variations across free-standing pediatric hospitals. Despite its low incidence, given the potentially lethal outcome of hospital discharge after T&A in patients with various risk factors, including clinical signs of OSA/SDB, overnight admission or prolonged postoperative monitoring is suggested in these patients. Furthermore, alterations in postoperative pain management practices with avoidance or limited use of opioids are suggested given the increased sensitivity of this patient population to the respiratory depressant effects of opioids.[@CIT0023],[@CIT0024] While there were no postoperative deaths reported in the database used for our study, the literature, and closed claims data clearly outline the risk in this patient population.
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Table S1Reasons for 7-day revisits according to hospital use of overnight stay after adenotonsillectomy (N=26,908 revisits)Revisit reasonInstitutional practice of overnight stay after T&A≤20% overnight stay\
(N=6,081)\
N (%) or mean (SD)21--35% overnight stay\
(N=10,275)\
N (%) or mean (SD)36--60% overnight stay\
(N=7,153)\
N (%) or mean (SD)\>60% overnight stay\
(N=3,399)\
N (%) or mean (SD)Bleeding1,009 (17%)2,288 (22%)1,205 (17%)755 (22%)Dehydration1,516 (25%)2,154 (21%)1,608 (22%)558 (16%)Fever432 (7%)559 (5%)382 (5%)219 (6%)Nausea/Vomiting307 (5%)551 (5%)414 (6%)138 (4%)Pain830 (14%)1,472 (14%)1,115 (16%)598 (18%)Other1,987 (33%)3,251 (32%)2,429 (34%)1,131 (33%)[^5] Table S2Multivariable mixed-effects logistic regression analysis of 7-day revisits among patients following T&A, omitting individual admission status (N=344,525)Institutional practice of overnight stay after T&A^a^OR95% CI*P*-value≤20% overnight stay1 (ref.)21--35% overnight stay0.95(0.90, 1.02)0.13836--60% overnight stay1.06(0.98, 1.15)0.135\>60% overnight stay0.91(0.82, 1.02)0.098[^6] Table S3Multivariable mixed-effects logistic regression analyses of 30-day revisits among patients following T&A, including or omitting individual admission status. (*N*=344,525)CharacteristicsModel including individual admission statusModel omitting individual admission statusORCI*P*ORCI*P*-valueOvernight stay after T&A0.76(0.74, 0.78)\<0.001------Age1.01(1.01, 1.01)\<0.0011.02(1.02, 1.02)\<0.001RaceWhite1 (ref.)1 (ref.)African American1.33(1.29, 1.37)\<0.0011.30(1.26, 1.34)\<0.001Other1.08(1.04, 1.12)\<0.0011.07(1.03, 1.11)\<0.001GenderFemale0.98(0.96, 1.00)0.0700.98(0.96, 1.01)0.149APR DRG Severity LevelMinor1 (ref.)1 (ref.)Moderate1.22(1.17, 1,26)\<0.0011.15(1.11, 1.19)\<0.001Major1.34(1.22, 1.46)\<0.0011.19(1.08, 1.30)\<0.001Extreme1.47(1.16, 1.88)0.0021.29(1.01, 1.64)0.040Presence of OSA or SDB symptoms1.01(0.98, 1.04)0.4060.96(0.94, 0.99)0.006Asthma1.33(1.28, 1.37)\<0.0011.32(1.28, 1.37)\<0.001Diabetes1.32(1.09, 1.61)0.0051.22(1.00, 1.48)0.046Obesity1.00(0.94, 1.07)0.9760.94(0.88, 1.00)0.066Year of service1.04(1.03, 1.05)\<0.0011.04(1.03, 1.05)\<0.001Annual volume of T&A procedures1.02(1.01, 1.02)\<0.0011.04(1.03, 1.05)\<0.001Institutional practice of overnight stay after T&A≤20% overnight stay1 (ref.)1 (ref.)21--35% overnight stay0.96(0.91, 1.02)0.1850.93(0.88, 0.98)0.01236--60% overnight stay1.07(1.00, 1.14)0.0681.01(0.94, 1.08)0.874\>60% overnight stay0.95(0.87, 1.05)0.3370.85(0.78, 0.94)0.001[^7]

[^1]: **Abbreviation:** ED, emergency department.

[^2]: **Note:** ^a^All categorical variables were statistically significantly different across groups (*P*\<0.001).

    **Abbreviations:** APR DRG, all patients refined diagnosis related groups; ED, emergency department; OSA, obstructive sleep apnea; SD, standard deviation; SDB, sleep-disordered breathing; T&A, adenotonsillectomy.

[^3]: **Note:** ^a^Reported values are in hundreds.

    **Abbreviations:** APR DRG, all patients refined diagnosis related groups; CI, confidence interval; OR, odds ratio; OSA, obstructive sleep apnea; SDB, sleep-disordered breathing; T&A, adenotonsillectomy.

[^4]: **Abbreviations:** APR DRG, All patients refined diagnosis related groups; CI, confidence interval; ED, emergency department; OR, odds ratio; OSA, obstructive sleep apnea; SDB, sleep-disordered breathing; T&A, adenotonsillectomy.

[^5]: **Abbreviations:** SD, standard deviation; T&A, adenotonsillectomy.

[^6]: **Note:** ^a^Odds ratios adjusted for all covariates shown in [Table 3](#T0006){ref-type="table"}, apart from individual admission status.

    **Abbreviations:** APR DRG, all patients refined diagnosis related groups; CI, confidence interval; OR, odds ratio; OSA, obstructive sleep apnea; SDB, sleep-disordered breathing; T&A, adenotonsillectomy.

[^7]: **Abbreviations:** APR DRG, all patients refined diagnosis related groups; CI, confidence interval; OR, odds ratio; OSA, obstructive sleep apnea; SDB, sleep-disordered breathing; T&A, adenotonsillectomy.
